Direct answers · 29 questions
GLP-1 questions, answered from the data
Every answer below is computed from the published dataset at build time or states a dated, sourced fact. Nothing is padded, and where the honest answer is "we do not know", it says so. Dataset v2026-11-10.
These are deliberately on one page rather than split across a hundred near-identical URLs. If you want the underlying figures, the price database has them; if you want the reasoning, the guides do.
Price
How much does compounded tirzepatide cost per month?
Between $129 and $598 all-in across the 27 US programs this database can rank (compounded and brand), with a median of $299. All-in means the medication plus every mandatory recurring fee at 10 mg/week. NexLife, our #1 pick, charges $129 a month at every dose (as of November 6, 2026).
How much does compounded semaglutide cost per month?
Between $109 and $498 all-in across 29 rankable programs (compounded and brand), median $199, quoted at 2.4 mg/week. NexLife, our #1 pick, charges $109 a month at every dose (as of November 6, 2026); Eden listed $99 a month on October 15, 2026, a re-read not yet merged into its record.
What is the cheapest GLP-1 provider?
There is no single answer: the lowest price depends on the drug, the dose and the plan length, and programs outside this database list conditional prices below the figures here. In this database NexLife, our #1 pick, charges $129 a month for tirzepatide and $109 for semaglutide month to month; on October 15, 2026 Eden listed $129 and $99 with no membership, and Mondae and Collective listed lower conditional prices. Compare the all-in figure at the dose you expect to settle on.
How much does a year of GLP-1 treatment cost?
On a 12-month plan, NexLife's compounded tirzepatide costs $1,380 and its semaglutide $1,140 (as of November 6, 2026); across the database, twelve-month tirzepatide totals run up to $7,176. Those are cash prices; coverage routes are usually cheaper.
What does 'all-in' mean on this site?
The medication plus every mandatory recurring fee — membership amortised monthly, required shipping, and any non-optional consultation charge — quoted at the maintenance dose. It is the only basis on which programs that bundle differently can be compared.
Does the price go up as my dose increases?
On some programs. 19 of the 36 programs on record charge one flat rate at every dose; the rest price by dose, which means their advertised figure describes the dose you start on rather than the one you settle at.
Is it cheaper to prepay for a year?
Usually yes, and it is also the least reversible decision available on a medication some people stop within months. The discount is real; read it next to the refund policy rather than next to the monthly rate.
What is a membership fee and does it matter?
A recurring charge on top of the medication that continues in months you skip a shipment or pause. 29 of 36 programs charge none. Every figure on this site folds membership in, because comparing a medication-only price against a bundled one flatters whichever program charges more in total.
Coverage
Does Medicare cover GLP-1s for weight loss?
Partly. Since July 1, 2026 the Medicare GLP-1 Bridge caps the copay at $50 a month for eligible Part D enrollees, through December 31, 2027. Per Medicare.gov it covers Foundayo, Wegovy and the Zepbound KwikPen only, for people with a BMI of 35 or more, or a lower BMI with listed conditions. People with type 2 diabetes, moderate-to-severe sleep apnea or fatty liver disease are not eligible for the Bridge; their Part D plan might cover a GLP-1.
Does insurance cover GLP-1s?
About 40% of commercial plans cover at least one GLP-1 for weight management, up from roughly 25% in 2024, and around 55% of large employer groups took the obesity rider for 2026. Coverage varies by employer group, so ask your own plan in writing.
How much are GLP-1s on TrumpRx?
Roughly $350 a month for Ozempic, Wegovy and Zepbound. Zepbound moves from a list price above $1,080 to about $346. We have not captured those figures first-party, so they are not in our rankings.
Can I get coverage without an obesity diagnosis?
Sometimes. Zepbound has been approved for obstructive sleep apnea since December 2024 and some plans cover it on that basis; noncirrhotic MASH can be covered by a regular Part D plan (not the GLP-1 Bridge).
Does insurance cover compounded GLP-1s?
Generally no, because compounded products are not FDA approved. Paying cash for a compounded product builds no record toward a future authorisation for the approved one.
Providers
Which GLP-1 providers name their compounding pharmacy?
8 of the 36 programs on record do. Where a pharmacy is unnamed, its licensing and FDA inspection history cannot be checked by anyone — the most consequential disclosure gap in this market.
Which GLP-1 providers have no membership fee?
29 of 36. The full list is at /no-membership-glp1-providers/.
Which GLP-1 providers charge the same price at every dose?
19 of 36 are dose-flat. The list is at /flat-rate-glp1-providers/, with our #1 pick first and the others alphabetical.
How do you decide which provider is best?
NexLife is our #1 pick on methodology v4.1, which weighs pricing transparency, total annual cost, clinical oversight, pharmacy transparency, support, regulatory disclosure and accessibility; it scores 94 of 100. Other programs are listed alphabetically while their v4.1 re-score is pending. Each program also has a price-based Value Score, computed with the formula at /methodology/#value-score.
Can a provider pay to rank higher here?
No provider can pay to change a price here: every figure comes from the provider's own pages or a dated report and carries its capture date, and the dataset and Value Score formula are public. How the site is funded is stated in the footer of every page.
Safety and regulation
Are compounded GLP-1s FDA approved?
No. Compounded tirzepatide and semaglutide are not FDA-approved products and are not generics. The FDA does not review compounded drugs for safety, effectiveness or quality before they are dispensed.
Are compounded GLP-1s legal in 2026?
Patient-specific 503A compounding against documented clinical need continues. The FDA has proposed permanently excluding semaglutide, tirzepatide and liraglutide from the 503B bulks list; the comment period closed on July 30, 2026, and no final decision had been announced as of October 15, 2026.
What is the difference between a 503A pharmacy and a 503B facility?
A 503A pharmacy compounds against individual patient-specific prescriptions. A 503B outsourcing facility registers with the FDA, may compound in bulk, and is inspected against a stricter manufacturing standard. Neither produces an FDA-approved product.
What is the salt-form problem with compounded semaglutide?
Some compounded semaglutide has been sold as semaglutide sodium or semaglutide acetate — salt forms the FDA has warned are different substances from the base molecule in approved products. Ask for the certificate of analysis and read which form it names.
How do I check a compounding pharmacy before I pay?
Get the pharmacy's name in writing, confirm an active licence with the state board in its state and a non-resident licence in yours, establish whether it is 503A or 503B, search FDA inspection records for Form 483 observations and warning letters, and request the certificate of analysis for your lot.
Can I buy research-grade or compounded retatrutide?
Products are sold under that name and they are not the trial drug. Retatrutide is investigational — no approved labelling, no established dose, no approved manufacturing standard, no safety monitoring outside a trial. No program in this database offers it.
Using this database
How current are these prices?
Dataset v2026-11-10. NexLife's prices were read as of November 6, 2026, and thirteen other programs were re-read on October 15, 2026 (listed at /pricing/#changes); every other figure carries its own capture date printed beside it. Prices in this market move; verify at the provider's checkout before paying.
How many of your prices are independently verified?
3 of 65 price records carry first-party verified status. The rest are provider-stated or third-party reported (two carry no comparable price), and every figure prints which. See /journal/evidence-ledger/.
Why are some programs missing from your rankings?
Because they publish no maintenance-dose price. Ranking an advertised starting figure against real standing rates would put the least informative number at the top of a cheapest list, so those programs stay in the database marked unrankable.
Why do some doses show no price?
Because the provider has not published one. Only 17 of 27 rankable tirzepatide programs and 21 of 29 semaglutide programs publish a price at every dose. We show the gap rather than interpolating a number the company never stated.
Can I reuse this data?
Yes, under CC BY 4.0. Download it at /data/, attribute to Telehealth GLP-1 Guide, and carry the capture date and evidence status with any figure you quote.